Work

Clinical characteristics and outcomes of trial-ineligible patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving androgen receptor targeted (ART) therapy.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.6_suppl.118

Authors: George Slade Mellgard, Stephen Mccroskery, Zakaria Chakrani, Nathaniel Saffran, Nicole Taylor, Bobby Chi-Hung Liaw, Matt D. Galsky, William K. Oh, Kai Tsao, Vaibhav G. Patel

Institutions: Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4324136553

Cites:

Cited by:

Related to: 10